For the active substances disodium phosphonate and potassium phosphonates, the risk assessment has not been finalised yet by the rapporteur Member State. Taking into account the subsequent steps to be completed in each renewal procedure, the duration of the extension of the approval periods of these active substances should be set at 42 months.
Recital 28, Regulation (EU) 2025/2316
In forcesince 17 Nov 2025